PSC
LIVE

Serial Number

88593588

Owner

PSC Biotech Corporation

Attorney

Griffin Lee

First Use Date

Dec 31, 2018

Filing Date

Aug 26, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PSC Trademark

Serial Number: 88593588 • Registration: 6428977

PSC is a trademark filed by PSC Biotech Corporation on August 26, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PSC Biotech Corporation (65 trademarks)

700 Corporate Center Dr, Suite 201
Pomona, CA 91768

Entity Type: 03

Trademark Details

Filing Date

August 26, 2019

Registration Date

July 20, 2021

First Use Anywhere

December 31, 2018

First Use in Commerce

February 3, 2012

Published for Opposition

July 21, 2020

Goods & Services

Technical consulting services in the fields of pharmaceuticals, biologics, biotechnology and medical devices for companies with manufacturing facilities, namely, providing technical information in the field of pharmaceutical manufacturing, and providing technical advice related to the manufacture of goods in the fields of pharmaceuticals, biologics, biotechnology and medical devices

Metrology equipment, namely, optical frequency metrology devices, scientific measuring instruments in the nature of conductivity meters, and scientific instrumentation for measuring weight, chemical levels in water; Downloadable and recorded software for operating electronic quality management systems, for use in conducting electronic quality management services, for use in operating temperature measurement and logging equipment, and for use in metrology operations, analyses, and functions and conducting metrology related services

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, biologics, biotechnology and medical device companies to assist them with clinical research, clinical trials and applications for drug approval before government agencies

Regulatory compliance consulting for companies with manufacturing facilities in fields of pharmaceuticals, biologics, biotechnology and medical devices, namely, regulatory compliance consulting with regulations promulgated by governmental agencies that regulate medicine; Professional commissioning services, namely, licensing of intellectual property and regulatory compliance auditing in the pharmaceutical, drug and medical industries; Professional qualification and validations services, namely, reviewing standards and practices to assure compliance with drug, medical, and pharmaceutical laws and regulations

Pharmaceutical consultation

Technical consulting services in the fields of pharmaceuticals, biologics, biotechnology and medical devices, namely, assisting companies with manufacturing facilities by providing technical consulting in the fields of pharmaceutical studies, and medical and scientific research in the fields of pharmaceuticals, biologics, biotechnology and medical devices; technical consulting services in the fields of pharmaceuticals, biologics, biotechnology and the medical device industry, namely, providing quality assurance services, and design and development of computer software; Metrology services; Electronic quality management services, namely, quality control of electronic goods and services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2022 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 3, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 3, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 3, 2021 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 4, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 4, 2021 REAP
REGISTERED-PRINCIPAL REGISTER
Jul 20, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 16, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 15, 2021 CNPR
ASSIGNED TO EXAMINER
Jun 15, 2021 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Mar 23, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 23, 2021 AITU
USE AMENDMENT FILED
Mar 4, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 4, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 15, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2020 CRFA
ASSIGNED TO LIE
Jun 8, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2020 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 20, 2020 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 20, 2020 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
May 20, 2020 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
May 20, 2020 CPEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 25, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 25, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 25, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 19, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 10, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2019 NWOS
NEW APPLICATION ENTERED
Aug 29, 2019 NWAP